SLU-PP-332: The ERRα Agonist That Gives You the Benefits of Exercise in a Vial

# SLU-PP-332: The ERRα Agonist That Gives You the Benefits of Exercise in a Vial

SLU-PP-332 is unlike most compounds in the biohacking world. It's not a peptide — it's a small synthetic molecule that activates estrogen-related receptor alpha (ERRα), one of the master regulators of mitochondrial biogenesis and fat metabolism. In animal studies, it produced dramatic improvements in endurance capacity without any additional training. The research community quickly labeled it an "exercise mimetic."

For people stacking it with GLP-1s, MOTS-C, or SS-31, SLU-PP-332 adds a distinct metabolic lever that none of those compounds fully cover.

What Is SLU-PP-332?

SLU-PP-332 was developed by researchers at Scripps Research as part of a program to find molecules that could activate nuclear hormone receptors involved in energy metabolism. ERRα is a transcription factor that regulates genes controlling:

• Mitochondrial biogenesis — building new mitochondria
• Oxidative phosphorylation — how efficiently cells produce ATP
• Fatty acid oxidation — how much fat gets burned for fuel
• Muscle fiber type switching — shifting toward slow-twitch oxidative fibers

When ERRα is activated, the metabolic effect resembles endurance exercise at the cellular level. The landmark 2023 paper showed that mice given SLU-PP-332 ran significantly further on a treadmill than untrained controls — without any exercise training.

How SLU-PP-332 Works

ERRα doesn't require an endogenous ligand (it's constitutively active but orphan receptor-class). SLU-PP-332 binds to its ligand-binding domain and increases its transcriptional activity.

The downstream effects:

• Upregulates PGC-1α — the primary driver of mitochondrial biogenesis
• Increases expression of genes for beta-oxidation (fat burning enzymes)
• Promotes type I (slow-twitch) muscle fiber characteristics
• Reduces fat mass, particularly visceral adipose
• Improves insulin sensitivity via enhanced glucose disposal

This is meaningfully different from MOTS-C (which activates AMPK and works through a mitochondrial peptide pathway) or SS-31 (which protects existing mitochondria from oxidative damage). SLU-PP-332 is upstream — it tells the genome to build more mitochondrial capacity.

SLU-PP-332 vs Other Metabolic Compounds

Compound	Mechanism	Primary Benefit	Best For
SLU-PP-332	ERRα agonism	Mitochondrial biogenesis, endurance, fat oxidation	Endurance athletes, fat loss, metabolic optimization
MOTS-C	AMPK activation	Mitochondrial function, insulin sensitivity	Active aging, recomp, GLP-1 augmentation
SS-31	Cardiolipin stabilization	Mitochondrial membrane protection	High training volume, recovery, cardiac health
GW501516 (Cardarine)	PPARδ agonism	Fat oxidation, HDL improvement	Similar profile to SLU-PP but different pathway

All four can be stacked because their mechanisms are complementary rather than redundant.

Dosing Protocol

SLU-PP-332 is a small molecule, not a peptide. This matters for dosing — the numbers are in milligrams, not micrograms.

Standard oral dosing:

• Starting dose: 5mg/day oral
• Effective range: 10–25mg/day
• Frequency: Daily or 5 days on/2 days off
• Cycle length: 4–8 weeks
• Timing: Morning fasted for maximum fat oxidation alignment

Sub-cutaneous dosing (if using injectable form):

• Same mg range as oral
• Reconstitute in DMSO + BAC water (DMSO first, then dilute)
• Example: 5mg vial + 0.5mL DMSO + 2mL BAC water = 2mg/mL
• At 2mg/mL: 10 units = 200mcg, 25 units = 500mcg, 50 units = 1mg, 100 units = 2mg
• Daily injection dose: 50–250 units depending on target
• Keep DMSO concentration ≤20% in final solution to minimize injection sting

Important: Oral is preferred by most users because bioavailability is reasonable (~40–60%) and it avoids the DMSO injection entirely. Capsules at 5–25mg/day are the most practical format.

SLU-PP-332 for Different Goals

Endurance and Athletic Performance

SLU-PP-332 is most backed by research for endurance. At 100-120km/week training volumes, it stacks powerfully with SS-31 — SLU-PP-332 builds more mitochondrial capacity while SS-31 protects existing mitochondria from the oxidative stress generated by that volume.

Dosing for endurance: 15–20mg/day oral, cycle 6–8 weeks.

Fat Loss and Body Recomposition

The fat oxidation effect is real and meaningful, particularly visceral adipose. SLU-PP-332 stacks well with GLP-1s (Retatrutide, Tirzepatide) — the GLP-1 handles appetite suppression while SLU-PP-332 increases the metabolic demand of the tissues, creating dual pressure on fat mass.

Dosing for fat loss: 10–15mg/day oral, can run continuously with periodic breaks.

Anti-Aging and Longevity

Mitochondrial decline is a primary driver of aging. SLU-PP-332's ability to stimulate new mitochondrial biogenesis makes it relevant for longevity stacks. Pairs well with Epitalon (cellular aging), NAD+ (mitochondrial fuel), and MOTS-C (mitochondrial signaling).

Stack Combinations

The Mitochondrial Triple Stack:

• SLU-PP-332 10–15mg/day oral (ERRα → biogenesis)
• MOTS-C 500mcg/day subQ (AMPK → function)
• SS-31 0.5mg/day subQ (cardiolipin → protection)

Three different mechanisms, three layers of mitochondrial optimization. This is the stack for serious endurance athletes or aggressive anti-aging protocols.

Fat Loss Augmentation with GLP-1:

• Retatrutide 1–3mg/week (GLP-1/GIP/glucagon → appetite + liver)
• SLU-PP-332 10mg/day oral (ERRα → fat oxidation)
• AOD-9604 300mcg/day fasted subQ (HGH fragment → adipose-specific)

Budget-friendly Starter:

• SLU-PP-332 10mg/day oral
• NAD+ 250–500mg/day (fuel the new mitochondria SLU-PP-332 builds)

Side Effects and Safety

SLU-PP-332 human data is limited — most research is preclinical (rodent models). Community reports suggest:

• Generally well-tolerated at 5–25mg/day oral
• Mild GI sensitivity in some people at higher doses (take with food if needed)
• Theoretical concern with long-term ERRα activation and cardiac tissue — not observed at typical doses but worth monitoring in people with pre-existing cardiac conditions
• No known hormonal interference — ERRα is distinct from estrogen receptors despite naming similarity
• Mild diuretic effect reported anecdotally

As with all research compounds, start at the low end (5mg/day), assess for 1–2 weeks, then escalate.

Reconstitution Guide (If Using Injectable)

• Draw 0.5mL DMSO into a clean syringe
• Slowly inject into the lyophilized SLU-PP-332 vial
• Let dissolve (roll gently, don't shake)
• Draw 1mL BAC water and slowly add to the vial
• Add another 1mL BAC water (total: 0.5mL DMSO + 2mL BAC = 2.5mL for 5mg vial)
• Final concentration: 2mg/mL
• Refrigerate; DMSO solutions can be kept 4–6 weeks

The DMSO is non-negotiable for this compound — SLU-PP-332 is hydrophobic and won't dissolve in BAC water alone. Keep final DMSO percentage around 20% to minimize injection site irritation.

Frequently Asked Questions

Q: Is SLU-PP-332 a peptide?

No. It's a small synthetic molecule — a selective nuclear receptor agonist. It's grouped with research peptides in community discussions but mechanistically it's more similar to SARMS or PPARδ agonists like Cardarine. This also means dosing is in mg, not mcg.

Q: Can I stack SLU-PP-332 with Cardarine (GW501516)?

Yes, they're complementary. SLU-PP-332 works via ERRα, Cardarine via PPARδ — different receptors with overlapping effects on fat oxidation and endurance. Stacking them gives you coverage across both pathways. Many serious endurance athletes run both.

Q: How quickly does SLU-PP-332 work?

Energy and endurance effects typically appear within 1–2 weeks. Full mitochondrial biogenesis benefits take 4–6 weeks to fully express since building new mitochondria is a slower cellular process.

Q: Is oral or injection better?

For most people, oral is better — simpler, no injection hassle, reasonable bioavailability. Sub-q is an option if you have lyophilized powder and want to avoid the digestive pathway, but the practical advantage is minimal.

Q: Where can I source SLU-PP-332?

Available from research chemical suppliers. American Peptide Research carries a range of research compounds — check their current catalog for availability.

---

Track Your Metabolic Stack

Running SLU-PP-332 alongside GLP-1s, MOTS-C, or SS-31? PeptIQ helps you track energy, recovery, body composition, and protocol adherence across your full stack — so you can see what's actually driving results.

Download PeptIQ — free to start.